NEUROPROTECTIVE ROLE OF A SMALL PEPTIDE DERIVED FROM NEURONAL CELL CYCLE LIKE KINASE (CDK5) ACTIVATOR (P35)

NEUROPROTECTIVE ROLE OF A SMALL PEPTIDE DERIVED FROM NEURONAL CELL CYCLE LIKE KINASE (CDK5) ACTIVATOR (P35)

Joint Event on International Conference on NEUROSCIENCE AND NEUROLOGICAL DISORDERS & International Conference on PSYCHIATRY AND PSYCHOLOGICAL DISORDERS
June 28-29 , 2018 | Dublin , Ireland

Harish C Pant

National Institutes of Health, USA

Scientific Tracks Abstracts : J Neurol Neurorehabil Res

Abstract:

In the face of the evidence-based literature bipolar disorder remains a difficult diagnosis, it is usually associated with comorbidities. Many patients report up to 10-year delay from symptom onset to correct diagnosis. It is estimated that 68% of the time they are in the depressive phase and is the cause of severe disability. It is noted the management of the depressive phase of the illness is even more challenging. There are several guidelines available currently for treatment of bipolar depression. The Canadian Association of mood and anxiety disorders came up with guidelines for treatment of bipolar type 2 depression which appears to be relatively unique. The use of atypical antipsychotics is becoming more popular these days compared to the mood stabilizers. In this presentation the speaker will attempt to help the audience achieve the above objectives. Review clinical aspects of bipolar depression and common comorbidities. Overview of current treatment guidelines for bipolar depression and discuss evidence-based treatment options and key considerations for bipolar depression.

Biography:

Tariq A Munshi is an Associate Professor in the Department of Psychiatry at Queens University, Kingston, Ontario. At present he is the Clinical Director of the Adult Community Division. He held the position of Clinical Director of the Acute Inpatient Unit between 2013 and 2016. He is a Lead Psychiatrist for the Assertive Community Treatment Team since 2009. He had joined the department as an Assistant Professor in March 2009 and was promoted to Associate Professor in July 2015. He trained in the University College of London, Camden and Islington Training Scheme Rotation. He did Medicine from Karachi, Pakistan practiced in Medicine and Family Medicine before going to the United Kingdom. He is interested in Schizophrenia, Severe Mental Illness and its management have done research on Antipsychotics, Severe Mental Illness and its relation to Metabolic Syndrome. He has presented in several national and international conferences since 2013.

E-mail: dtariq2000@yahoo.com

PDF HTML